Introducing Pulmolisa, a simple blood test for the early detection and differential diagnosis of lung cancer developed by Biosystems Immunolab.
Biosystems Immunolab is an in-vitro diagnostics R&D company delivering solutions for the early detection of cancer using its protected protein epitome profiling technology platform for the discovery and development of disease-specific plasma protein epitope panels (multivariate index assays) that can be run on popular validated protein array and ELISA platforms. Pulmolisa is our first product.
Our mission: To improve health by the timely detection of cancer and treatment of inflammatory diseases.